TRICYCLIC COMPOUNDS PROVIDING DESTRUCTION OF IKAROS PROTEIN AND AIOLOS PROTEIN Russian patent published in 2025 - IPC C07D209/92 A61K31/403 A61K31/4545 A61K31/5377 A61P35/00 A61P35/02 

Abstract RU 2833608 C2

FIELD: chemistry; pharmaceutics.

SUBSTANCE: invention relates to organic chemistry and pharmaceutics, specifically a compound of formula I or formula II, or a pharmaceutically acceptable salt thereof, compound 218, its enantiomers, pharmaceutically acceptable salts which bind Cereblon for breaking down the Ikaros protein or the Aiolos protein via the ubiquitin-proteasome pathway, a pharmaceutical composition based thereon, their use for the preparation of a therapeutic agent and a method of treating a disorder which is cancer or a tumour mediated by cerebellum in a human being. In general formula I or formula II, X1 and X2 are independently selected from CH and N; X3 is selected from communication, NR2, C(R3R3’), O, C(O), C(S), S, S(O) and S(O)2; R1 is selected from hydrogen, halogen, cyano, nitro, NH2, -OH, -NR2R4, -OR4, -(CR3R3’)-R4, -C(O)R4, -SR4, -S(O)R4 and -S(O)2R4; R20, R21, R22, R23 and R24 independently in each case are selected from a group consisting of a bond, C1-C4 alkyl, -C(O)-, -C(O)O-, -OC(O)-, -SO2-, -S(O)-, -C(S)-, -C(O)NR2-, -NR2C(O)-, -O-, -S-, -NR2-, -P(O)(R28)-, -P(O)-, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 haloalkyl, C6-C14 aryl, 3–14-membered heterocycle with 1–3 heteroatoms selected from nitrogen, sulphur and oxygen, 5–10-member heteroaryl with 1–3 heteroatoms selected from nitrogen, sulphur and oxygen, bicyclic and C3-C8 cycloalkyl; each of them is optionally substituted with 1, 2, 3 or 4 substituents independently selected from R40; and where R20, R21, R22, R23 and R24 cannot be selected so that -C(O)-, -C(O)O-, -OC(O)-, -SO2-, -S(O)-, -P(O)(R28)-, -P(O)- and -C(S)- fragments are adjacent to each other; or -O-, -S- or -NR2- fragments are adjacent to each other; R25 is selected from hydrogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, halogen, hydroxyl, C1-C4 alkoxy, azide, amino, cyano, -OR2, -NR2R2’, -NR2SO2R28, -OSO2R28, -SO2R28, C1-C4 haloalkyl, C6-C14 aryl, 5–10-membered heteroaryl with 1–3 heteroatoms selected from nitrogen, sulphur and oxygen, 3–14-membered heterocycle with 1–3 heteroatoms selected from nitrogen, sulphur and oxygen, bicycle and C3-C8 cycloalkyl; each of such R25 groups is optionally substituted with 1, 2, 3 or 4 groups independently selected from R12. Other values of radicals are given in the claim.

EFFECT: disclosed are tricyclic compounds which provide for the destruction of the Ikaros protein and the Aiolos protein.

233 cl, 2 tbl, 295 ex

Similar patents RU2833608C2

Title Year Author Number
COMPOUNDS TARGETING TAU PROTEIN AND RELATED USE THEREOF 2017
  • Crew, Andrew, P.
  • Berlin, Michael
  • Flanagan, John, J.
  • Dong, Hanqing
  • Ishchenko, Alexey
RU2805523C2
POLYCYCLIC COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF POLYPEPTIDES OF FAST ACCELERATED FIBROSARCOMA 2019
  • Crew, Andrew P.
  • Hornberger, Keith R.
  • Wang, Jing
  • Crews, Craig M.
  • Jaime-Figueroa, Saul
  • Dong, Hanqing
  • Qian, Yimin
  • Zimmerman, Kurt
RU2830173C2
THIENOPYRAZOLES 2004
  • Jurchak Dzhon Zherard
  • Barrag Mat'E
  • Dzhillespaj Timoti Alan
  • Ehdvards Majkl Lui
  • M'Jusik Kvon Jon
  • Vehjntraub Filip Marvin
  • Du Jan'
  • Dkharanipragada Ramalinga M.
  • Parkar Ashfak Akhmed
RU2358978C2
HYDROXYPURINE COMPOUNDS AND USE THEREOF 2016
  • Wu, Lingyun
  • Chen, Xiaoxin
  • Zhang, Peng
  • Liu, Xing
  • Zhang, Li
  • Liu, Zhuowei
  • Chen, Shuhui
  • Long, Chaofeng
RU2685417C1
5-AZAINDAZOLE COMPOUNDS AND METHODS FOR USE THEREOF 2013
  • Deu Stiven
  • Khu Khuejyun
  • Kolesnikov Aleksandr
  • Tsui Viki Kh.
  • Van Syaotszin
RU2665462C2
KINASE INHIBITORS 2013
  • Alkara, Lilian
  • Panchal, Terri Aaron
  • Dzhenningz, Endryu Stefen Robert
  • Kridlend, Endryu Piter
  • Kharli, Kristofer
RU2637944C2
AMINOTRIAZOLOPYRIDINES AND USING THEM AS KINASE INHIBITORS 2009
  • Bamaniar Sogole
  • Behjts R. Dzh.
  • Blis Kejt
  • Kalabreze Ehndrju Ehntoni
  • Dehniel Tomas Oran
  • Del'Gado Mersedes
  • Ehl'Sner Jan
  • Ehrdman Pol
  • Far Brjus
  • Fergjuson Gregori
  • Li Brehnden
  • Nadol'Ny Liza
  • Pakard Garrik
  • Papa Patrik
  • Plantevin-Krenitski Veronik
  • Riggs Dzhennifer
  • Roan Patrisija
  • Sankar Sabita
  • Sapienza Dzhon
  • Satokh Esitaka
  • Sloan Viktor
  • Stivens Rehndall
  • Terani Lida
  • Tike Dzhehjehshri
  • Torres Ehduardo
  • Uollehjs Ehndrju
  • Vajtfild Brehndon Uehjd
  • Chzhao Tszintszin
RU2552642C2
SUBSTITUTED PYRAZOLOPYRIMIDINES AND SUBSTITUTED PURINES AND USE THEREOF AS INHIBITORS OF UBIQUITIN-SPECIFIC PROCESSING PROTEASE 1 (USP1) 2019
  • Brenneman, Dzherod Bernett
  • Kroll, Elza Bejer
  • Shlabakh, Majkl
  • Vajli, Endryu Alister
RU2833222C2
CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF 2020
  • Du, Vu
  • Ven, Kun
  • Fu, Ivej
  • Lv, Khajbin
  • Khe, Tszinyun
  • Tsin, Dekun
  • Li, Yuj
  • Duan, Tszini
  • Li, Yun
  • Aj, Chaovu
  • Tu, Chzhilin
  • Chen, Yuanvej
  • Li, Sinkhaj
  • Li, Khajbo
RU2825000C2
3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND VARIANTS OF THEIR USE 2018
  • Beckwith, Rohan Eric John
  • Bonazzi, Simone
  • Cernijenko, Artiom
  • Fazal, Aleem
  • Tichkule, Ritesh Bhanudasji
  • Visser, Michael Scott
RU2795850C2

RU 2 833 608 C2

Authors

Khenderson, Dzhejms, A.

Khe, Minshen

Gud, Endryu, Charlz

Filipps, Endryu, Dzh.

Dates

2025-01-27Published

2020-04-10Filed